| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
64 － ? |
Tetracycline (Sumycin, Achromycin V, Steclin)  |
476 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
400 － ? |
Naringenin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
1600 － ? |
3,7-dihydroxyflavone |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
1600 － ? |
Flavone |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
>3200 － ? |
Fisetin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
3200 － ? |
Hesperetin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
>3200 － ? |
Hesperidin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
3200 － ? |
Naringin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
>3200 － ? |
Quercetin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate) |
- |
- |
3200 － ? |
Rutin |
1549 |
| Staphylococcus aureus (vancomycin-intermediate-resistant) |
- |
- |
2 － ? |
Microbisporicin |
801 |
| Staphylococcus aureus (vancomycin-intermediate-resistant) |
- |
- |
32 － ? |
Nisin |
801 |
| Staphylococcus aureus (vancomycin-intermediate-resistant) |
- |
- |
128 － ? |
Actagardine |
801 |
| Staphylococcus aureus (vancomycin-intermediate-resistant) |
- |
- |
128 － ? |
Mersacidin |
801 |
| Staphylococcus aureus (vancomycin-intermediate-resistant) |
- |
- |
128 － ? |
Planosporicin |
801 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
>0.062 |
>64 |
0.062 － >64 |
Rifampicin (Rifampin) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
0.25 |
2 |
0.062 － >64 |
Fusidic acid (Fucidin) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
0.5 |
1 |
0.125 － 4 |
GSQ1530 |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
2 |
4 |
0.4 － 8 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
4 |
8 |
2 － 16 |
Vancomycin (Vancocyn, Lyphocin) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
>32 |
>64 |
0.5 － >64 |
Ofloxacin (Floxin) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
>64 |
>64 |
0.5 － >64 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
>64 |
>64 |
2 － >64 |
Ampicillin (Omnipen) |
1060 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
- |
- |
0.25 － 0.25 |
Quinupristin/Dalfopristin (Synercid) |
7 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
- |
- |
0.5 － 1 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
- |
- |
1 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
7 |
| Staphylococcus aureus (vancomycin-intermediate-susceptible) |
- |
- |
8 － 8 |
Vancomycin (Vancocyn, Lyphocin) |
7 |
| Staphylococcus aureus (vancomycin-resistant + Michigan) |
- |
- |
1 － 2 |
A-80915A |
1001 |